To dry or not too dry: Should we be more tolerant of stable subretinal fluid in patients receiving anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration?

H. Razavi, J. Arnold, R. Guymer

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
Original languageUndefined/Unknown
JournalClinical and Experimental Ophthalmology
DOIs
Publication statusPublished - 2015
Externally publishedYes

Cite this